Winton Capital »

Allogene Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $296k 121k 2.44
2023-03-31 $184k 37k 4.94
2022-12-31 $220k 35k 6.29
2022-09-30 $359k 33k 10.79
2022-06-30 $441k 39k 11.41
2022-03-31 $278k 31k 9.12
2021-12-31 $366k 25k 14.90
2021-09-30 $771k 30k 25.69
2021-06-30 $826k 32k 26.08
2021-03-31 $703k 20k 35.31
2020-12-31 $566k 22k 25.22
2020-09-30 $3.4M 89k 37.71
2020-06-30 $2.3M 54k 42.82
2020-03-31 $937k 48k 19.44
2019-12-31 $1.1M 42k 25.98